Atlas Trials

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Clinical trial NCT02317302 · TERMINATED

Trial details

NCT number
NCT02317302
Sponsor
Washington University School of Medicine
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cervical CancerUterine Cervical CancerUterine Cervical Neoplasms
Start date
2011-06-28
Primary completion
2020-06-02
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.